Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective studyNallamothu BK, Normand SL, Wang Y et al. -
Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?Berry C, Collison D, Mangion K.
-
Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney diseaseDégano IR, Subirana I, EUROTRACS investigators
-
Application of High-Sensitivity Troponin in Suspected Myocardial InfarctionJT Neumann, R Twerenbold, F Ojeda et al.
-
Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction RegistryYang Y, CAMI Registry study group.
-
Multivessel PCI Guided by FFR or Angiography for Myocardial InfarctionE Puymirat, G Cayla, for the FLOWER-MI Study Investigators et al.
-
Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of InjurySAJ Damen, GE Cramer, H-J Dieker et al.
-
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trialJ Tuñón, PG Steg, ODYSSEY OUTCOMES Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
